Research, page-2696

If there was anything positive then company would have explicitly said something like this in the quarterly:

"We are happy to advise that since approval of the reimbursement we had 200 patient utilised our technology in just last two months over 2 hospital which is encouraging sign ... " The stock then would have rocketed to the moon not to the opposite.

This news is nothing, if doctors not recommending even after it get reimbursement approved and you don't have any disclosable data for last 2 month's scan since approval (actually it is 4th month running since approval in April !).